130 related articles for article (PubMed ID: 20145617)
1. MEPE/OF45 as a new target for sensitizing human tumour cells to DNA damage inducers.
Zhang P; Wang H; Rowe PS; Hu B; Wang Y
Br J Cancer; 2010 Mar; 102(5):862-6. PubMed ID: 20145617
[TBL] [Abstract][Full Text] [Related]
2. MEPE/OF45 protects cells from DNA damage induced killing via stabilizing CHK1.
Liu S; Wang H; Wang X; Lu L; Gao N; Rowe PS; Hu B; Wang Y
Nucleic Acids Res; 2009 Dec; 37(22):7447-54. PubMed ID: 19808933
[TBL] [Abstract][Full Text] [Related]
3. A small peptide mimicking the key domain of MEPE/OF45 interacting with CHK1 protects human cells from radiation-induced killing.
Yu X; Wang H; Liu S; Zhang X; Guida P; Hu B; Wang Y
Cell Cycle; 2010 May; 9(10):1981-5. PubMed ID: 20436300
[TBL] [Abstract][Full Text] [Related]
4. Regulation of mRNA expression of matrix extracellular phosphoglycoprotein (MEPE)/ osteoblast/osteocyte factor 45 (OF45) by fibroblast growth factor 2 in cultures of rat bone marrow-derived osteoblastic cells.
Zhang GX; Mizuno M; Tsuji K; Tamura M
Endocrine; 2004 Jun; 24(1):15-24. PubMed ID: 15249699
[TBL] [Abstract][Full Text] [Related]
5. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
[TBL] [Abstract][Full Text] [Related]
6. Radiation activated CHK1/MEPE pathway may contribute to microgravity-induced bone density loss.
Zhang X; Wang P; Wang Y
Life Sci Space Res (Amst); 2015 Nov; 7():53-6. PubMed ID: 26553637
[TBL] [Abstract][Full Text] [Related]
7. Targeted radiosensitization by the Chk1 inhibitor SAR-020106.
Borst GR; McLaughlin M; Kyula JN; Neijenhuis S; Khan A; Good J; Zaidi S; Powell NG; Meier P; Collins I; Garrett MD; Verheij M; Harrington KJ
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1110-8. PubMed ID: 22981708
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpoints.
Tao Y; Leteur C; Yang C; Zhang P; Castedo M; Pierré A; Golsteyn RM; Bourhis J; Kroemer G; Deutsch E
Cell Cycle; 2009 Apr; 8(8):1196-205. PubMed ID: 19305158
[TBL] [Abstract][Full Text] [Related]
9. Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction.
Stingl L; Stühmer T; Chatterjee M; Jensen MR; Flentje M; Djuzenova CS
Br J Cancer; 2010 May; 102(11):1578-91. PubMed ID: 20502461
[TBL] [Abstract][Full Text] [Related]
10. Need radioprotection? A MEPE/OF45 mimetic may do the job.
Li CY
Cell Cycle; 2010 Jun; 9(12):2271. PubMed ID: 20581437
[No Abstract] [Full Text] [Related]
11. MEPE/OF45, a new dentin/bone matrix protein and candidate gene for dentin diseases mapping to chromosome 4q21.
MacDougall M; Simmons D; Gu TT; Dong J
Connect Tissue Res; 2002; 43(2-3):320-30. PubMed ID: 12489176
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass.
Gowen LC; Petersen DN; Mansolf AL; Qi H; Stock JL; Tkalcevic GT; Simmons HA; Crawford DT; Chidsey-Frink KL; Ke HZ; McNeish JD; Brown TA
J Biol Chem; 2003 Jan; 278(3):1998-2007. PubMed ID: 12421822
[TBL] [Abstract][Full Text] [Related]
13. Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins.
Huang M; Miao ZH; Zhu H; Cai YJ; Lu W; Ding J
Mol Cancer Ther; 2008 Jun; 7(6):1440-9. PubMed ID: 18566216
[TBL] [Abstract][Full Text] [Related]
14. New partners for Chk1.
Iliakis G
Cell Cycle; 2010 Jun; 9(11):2061-2. PubMed ID: 20559029
[No Abstract] [Full Text] [Related]
15. The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress.
Zhang YW; Brognard J; Coughlin C; You Z; Dolled-Filhart M; Aslanian A; Manning G; Abraham RT; Hunter T
Mol Cell; 2009 Aug; 35(4):442-53. PubMed ID: 19716789
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo radiation sensitization of human tumor cells by a novel checkpoint kinase inhibitor, AZD7762.
Mitchell JB; Choudhuri R; Fabre K; Sowers AL; Citrin D; Zabludoff SD; Cook JA
Clin Cancer Res; 2010 Apr; 16(7):2076-84. PubMed ID: 20233881
[TBL] [Abstract][Full Text] [Related]
17. CHK1 affecting cell radiosensitivity is independent of non-homologous end joining.
Wang H; Hu B; Liu R; Wang Y
Cell Cycle; 2005 Feb; 4(2):300-3. PubMed ID: 15655357
[TBL] [Abstract][Full Text] [Related]
18. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.
Xiao Z; Chen Z; Gunasekera AH; Sowin TJ; Rosenberg SH; Fesik S; Zhang H
J Biol Chem; 2003 Jun; 278(24):21767-73. PubMed ID: 12676925
[TBL] [Abstract][Full Text] [Related]
19. Chk1 signaling pathways that mediated G(2)M checkpoint in relation to the cellular resistance to the novel topoisomerase I poison BNP1350.
Yin MB; Hapke G; Wu J; Azrak RG; Frank C; Wrzosek C; Rustum YM
Biochem Biophys Res Commun; 2002 Jul; 295(2):435-44. PubMed ID: 12150968
[TBL] [Abstract][Full Text] [Related]
20. In situ localization and in vitro expression of osteoblast/osteocyte factor 45 mRNA during bone cell differentiation.
Igarashi M; Kamiya N; Ito K; Takagi M
Histochem J; 2002 May; 34(5):255-63. PubMed ID: 12588003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
